Hypo-pharyngeal cancer
Showing 1 - 25 of >10,000
Oral Cancer, Hypopharyngeal Cancer Trial in Taichung City (Specific acupuncture group, Metoclopramide 10mg, Non-specific
Completed
- Oral Cancer
- Hypopharyngeal Cancer
- Specific acupuncture group
- +2 more
-
Taichung City, Taichung, Taiwansurgical and burn intensive care departments and the plastic sur
Mar 23, 2021
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)
Active, not recruiting
- Lung Cancer, Non-small Cell
- hypofractionated radiation therapy
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Mar 13, 2023
Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)
Not yet recruiting
- Prostate Cancer
- Radiotherapy standard
- Radiotherapy Hypo-FLAME
- (no location specified)
Jan 30, 2023
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left
Not yet recruiting
- Breast Cancer Female
- (no location specified)
Apr 27, 2022
Cancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis Trial in Lake Success (Ketamine Topical)
Not yet recruiting
- Cancer of Head and Neck
- +2 more
- Ketamine Topical
-
Lake Success, New YorkCenter for Advanced Medicine
Nov 1, 2022
Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority
Recruiting
- Prostate Cancer
- +2 more
- Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
- +7 more
-
Quebec, CanadaCHUdeQuebec
Apr 7, 2023
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Split-course hypo-CCRT
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Aug 26, 2023
Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,
Recruiting
- Prostate Cancer
- +2 more
- Moderate hypo-fractionation
- Ultra-hypo-fractionation
-
Umeå, SwedenCancercenter University hospital of Umeå
Nov 1, 2022
Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Kolkata (Hypo fractionated whole breast radiotherapy)
Unknown status
- Breast Cancer
- +2 more
- Hypo fractionated whole breast radiotherapy
-
Kolkata, West Bengal, IndiaSanjoy Chatterjee
Dec 2, 2021
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023
Prostate Adenocarcinoma, Prostate Cancer, Prostate Tumor Trial in Leuven, Amsterdam, Nijmegen (Hypo-FLAME 2.0 study)
Active, not recruiting
- Prostate Adenocarcinoma
- +2 more
- Hypo-FLAME 2.0 study
-
Leuven, Belgium
- +2 more
Jun 7, 2022
Breast Cancer, Radiotherapy; Complications Trial (Hypofractionation, Conventional Fractionation)
Not yet recruiting
- Breast Cancer
- Radiotherapy; Complications
- Hypofractionation
- Conventional Fractionation
- (no location specified)
Feb 23, 2022
Cervical Carcinoma, Endometrial Carcinoma Trial in Salt Lake City (Hypofractionated Radiation Therapy)
Recruiting
- Cervical Carcinoma
- Endometrial Carcinoma
- Hypofractionated Radiation Therapy
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Mar 1, 2022
Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)
Recruiting
- Glioblastoma
- +3 more
- Procedure: LITT
- Hypo-Fractionated Radiation Therapy
-
Baltimore, Maryland
- +3 more
Oct 10, 2022
Cervix Uteri Cancer Trial in Tehran (Hypofractionated EBRT, Standard EBRT)
Recruiting
- Cervix Uteri Cancer
- Hypofractionated EBRT
- Standard EBRT
-
Tehran, Iran, Islamic Republic ofImam Khomeini Hospital Complex
Oct 11, 2021
Swallowing Patient Reported Outcomes After Total
Recruiting
- Pharyngeal Cancer
- +2 more
-
Valence, Drome, FranceCh Valence
Aug 10, 2022
NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- Stereotactic body radiotherapy
- +2 more
- (no location specified)
Jul 5, 2022
Microbiome in Head and Neck Squamous Cell Carcinoma
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Metagenomic sequencing
- Metabolic analysis
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Apr 19, 2023
Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between
Recruiting
- Prostate Cancer
- +5 more
- grade and compare reported side effects between groups
-
Quebec, CanadaCHUdeQuebec
Mar 14, 2023
Prostate Adenocarcinoma, Radiation Toxicity Trial in Limassol (External beam radiation therapy, High-dose-rate brachytherapy,
Recruiting
- Prostate Adenocarcinoma
- Radiation Toxicity
- External beam radiation therapy, High-dose-rate brachytherapy
- Goserelin 10.8 mg
-
Limassol, CyprusGerman Oncology Center
Aug 6, 2021
Skin Cancer, Non-Melanoma Trial (Surgery with additional moderate hypofractionation RT (15 fractions), Surgery alone, without
Not yet recruiting
- Skin Cancer, Non-Melanoma
- Surgery with additional moderate hypofractionation RT (15 fractions)
- +2 more
- (no location specified)
Mar 20, 2023
Oral Cancer, Pharynx Cancer, Sleep Apnea Trial (Ronco-Onco and MAD)
Not yet recruiting
- Oral Cancer
- +4 more
- Ronco-Onco and MAD
- (no location specified)
Jan 30, 2023
Bladder Cancer Trial in Seoul (hypo-IMRT)
Recruiting
- Bladder Cancer
- hypo-IMRT
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 6, 2022
Prostate Cancer Trial in Ann Arbor (Ultra-hypofractionated radiation therapy, Moderately Hypo-fractionated Radiation Therapy)
Recruiting
- Prostate Cancer
- Ultra-hypofractionated radiation therapy
- Moderately Hypo-fractionated Radiation Therapy
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021